Back to top

Image: Bigstock

Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

For the quarter ended September 2025, Tenet Healthcare (THC - Free Report) reported revenue of $5.29 billion, up 3.3% over the same period last year. EPS came in at $3.70, compared to $2.93 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $5.24 billion, representing a surprise of +1.02%. The company delivered an EPS surprise of +11.11%, with the consensus EPS estimate being $3.33.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Adjusted admissions: 215.46 thousand versus 236.64 thousand estimated by two analysts on average.
  • Net patient service revenue per adjusted admission: $16,068.00 versus the two-analyst average estimate of $15,358.90.
  • Adjusted patient admissions - Same-hospital: 212.37 thousand versus 216.54 thousand estimated by two analysts on average.
  • Net Operating revenues: $5.29 billion compared to the $5.24 billion average estimate based on five analysts. The reported number represents a change of +3.3% year over year.
  • Net Operating revenues- Ambulatory Care: $1.28 billion compared to the $1.26 billion average estimate based on four analysts. The reported number represents a change of +11.9% year over year.
  • Net Operating revenues- Hospital Operations and Services: $4.01 billion versus the four-analyst average estimate of $3.99 billion. The reported number represents a year-over-year change of +0.8%.
  • Equity in earnings of unconsolidated affiliates: $64 million compared to the $64.77 million average estimate based on five analysts.
  • Adjusted EBITDA- Ambulatory Care: $492 million versus the three-analyst average estimate of $473.87 million.
  • Adjusted EBITDA- Hospital Operations and Services: $607 million versus $563.81 million estimated by three analysts on average.
  • Equity in earnings of unconsolidated affiliates- Hospital Operations and Services: $1 million versus $2 million estimated by two analysts on average.
  • Equity in earnings of unconsolidated affiliates- Ambulatory Care: $63 million versus the two-analyst average estimate of $64.42 million.

View all Key Company Metrics for Tenet here>>>

Shares of Tenet have returned +7.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Tenet Healthcare Corporation (THC) - free report >>

Published in